@ShahidNShah
How AI Could Make Every Disease A Rare Disease
Treating over 10,000 different rare conditions requires a radically new approach to drug discovery: artificial intelligence. There has been an encouraging trend in our understanding of rare diseases in recent years. The number of recognized rare diseases where the number of those affected is one in 2,000 people or fewer—has been steadily increasing. For the last decade, the number stood between 7,000 and 8,000, but thanks to new research, including RareX's Power of Being Counted report, the number now stands at 10,867. This does not mean more and more conditions are suddenly developing, to be clear; rather, our ability to understand and distinguish between them, or diagnose them, has improved. But this presents both a challenge and an opportunity for the biotech and pharma sectors.
Medigy Insights
Treating over 10,000 rare conditions requires a new approach to drug discovery: artificial intelligence (AI). The number of recognized rare diseases has increased to 10,867 from 7,000 to 8,000 due to improved diagnosis. This presents a challenge and an opportunity for biotech and pharma sectors. AI can expedite drug discovery by identifying drug targets, predicting adverse drug reactions, and personalizing treatments. It can also reduce the cost and time required for drug development and expand treatment options for patients.
Continue reading at forbes.com
Make faster decisions with community advice
- Automatic Identification of Heart Failure Diagnostic Criteria, Using Text Analysis of Clinical Notes from Electronic Health Records
- FOQUS: A Smartwatch Application for Individuals with ADHD and Mental Health Challenges
- From hospital to home: Rooming-in program provides peace of mind for families and nurses
- Health IT leaders must attend to interoperability, value-based care and AI
- Healthcare must control the 'whether, when and how' of AI development and deployment
Next Article
-
Healthcare must control the 'whether, when and how' of AI development and deployment
At the HIMSS23 opening keynote discussion, artificial intelligence innovators debated about how to weigh the "tremendous opportunities" for healthcare algorithms with the "risks – some of which we may …